{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-015059","form_type":"8-K","ticker":"XFOR","cik":"0001501697","company_name":"X4 Pharmaceuticals, Inc","filed_at":"2024-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.699763+00:00","generated_at":"2026-06-04T01:47:19.453094+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"X4 Pharmaceuticals regains Nasdaq bid price compliance; deficiency notice closed","bullets":["Received Nasdaq deficiency notice on Nov 13, 2023 for bid price below $1.00 for 30 consecutive trading days.","On April 5, 2024, Nasdaq confirmed compliance with Bid Price Rule; matter now closed.","Common stock (XFOR) remains listed on The Nasdaq Stock Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-015059","json":"https://secwatch.observer/filing/0001628280-24-015059.json","markdown":"https://secwatch.observer/filing/0001628280-24-015059.md","text":"https://secwatch.observer/filing/0001628280-24-015059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501697/000162828024015059/0001628280-24-015059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501697/000162828024015059/xfor-20240405.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T01:47:19.453094+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}